Drug
Genakumab
Genakumab is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_3
1
25%
Ph not_applicable
1
25%
Ph phase_1
2
50%
Phase Distribution
2
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
2(50.0%)
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(1)
Other(2)
Detailed Status
unknown2
Recruiting1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 12 (50.0%)
Phase 31 (25.0%)
N/A1 (25.0%)
Trials by Status
recruiting125%
unknown250%
completed125%
Recent Activity
1 active trials
Showing 4 of 4
completedphase_3
Safety & Efffficacy of Genakumab in Patients With Frequent Flares
NCT05983445
recruitingnot_applicable
To Evaluate the Efficacy and Safety of Genalumab for Injection in the Treatment of Active Systemic Juvenile Idiopathic Arthritis.
NCT05925452
unknownphase_1
Genakumab Alone and in Combination With Tislelizumab in Patients With Advanced Malignant Solid Tumors
NCT05441046
unknownphase_1
Clinical Study of Genakumab for Injection in Chinese Healthy Volunteers
NCT04337437
Clinical Trials (4)
Showing 4 of 4 trials
NCT05983445Phase 3
Safety & Efffficacy of Genakumab in Patients With Frequent Flares
NCT05925452Not Applicable
To Evaluate the Efficacy and Safety of Genalumab for Injection in the Treatment of Active Systemic Juvenile Idiopathic Arthritis.
NCT05441046Phase 1
Genakumab Alone and in Combination With Tislelizumab in Patients With Advanced Malignant Solid Tumors
NCT04337437Phase 1
Clinical Study of Genakumab for Injection in Chinese Healthy Volunteers
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4